Back to search

University of Edinburgh

Genomic analysis of dysplastic lesions in Inflammatory bowel disease

Abstract

dc:description.abstract

Inflammatory bowel disease (IBD)-associated dysplasia refers to precancerous abnormal cell growth in the colorectal epithelium of individuals with chronic IBD. Current methods for predicting colorectal cancer risk in patients with IBD-associated low-grade dysplasia are limited, and its molecular landscape remains underexplored. This study utilises whole exome sequencing of longitudinal, histopathologically graded dysplastic lesions to comprehensively analyse the genetic alterations and molecular characteristics underlying dysplasia and cancer progression. Lesions that progressed to high-grade dysplasia or carcinoma exhibited a higher frequency of TP53 mutations and widespread DNA copy number alterations compared with lesions that did not progress. These findings support TP53 mutation and genomic instability as key early drivers of neoplastic progression in IBD. Incorporating genomic testing for copy number alterations and TP53 mutations could improve clinical risk stratification and inform more personalised surveillance and management strategies for patients with IBD-associated dysplasia.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cheema, Saamin Akram
Advisors dc:contributor.advisor
  • Arends, Mark
  • Adams, Dave
  • Din, Shahida

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Cheema, Saamin Akram. Genomic analysis of dysplastic lesions in Inflammatory bowel disease. 2026. https://hdl.handle.net/1842/45476